Clinical Trial Update: Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab in children and young adults with Neurofibromatosis Type 2 and progressive vestibular schwannomas has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type 2
• Progressive Vestibular Schwannomas

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Neurofibromatosis Type 2, Progressive Vestibular Schwannomas | Phase 2 | Status: COMPLETED | Results posted: 2020-05-27